BOC ACM Briefing Document

First Page		Document Content
Pharmacology Biology Boceprevir Telaprevir Hepatitis C and HIV co-infection Ribavirin Peginterferon alfa-2a Interferon Hepatitis C Antivirals Protease inhibitors Medicine		BOC ACM Briefing Document Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 1,05 MB Share Document on Facebook

	Pegasys, INN-peginterferon alfa-2a DocID: 1tovV - View Document
	Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio DocID: 1owMZ - View Document
	NIH Public Access Author Manuscript J Hepatol. Author manuscript; available in PMC 2012 July 1. NIH-PA Author Manuscript DocID: 1gmiC - View Document
	PPAfactors-associated-with-hepatitis-c-treatment-uptake--adhere DocID: 1ghUZ - View Document
	SUPPLEMENT ARTICLE Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs Geert Robaeys,1,2,3,a Jason Grebely,4,a Stefan Mauss,5 Philip Bruggmann,6 Joseph Moussalli,7,8 Andrea De DocID: 1g6DC - View Document